5:01 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Bone Biologics Nasdaq/NYSE Compliance Notice
Bone Biologics Corp received a deficiency notice from Nasdaq on September 10, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, until March 9, 2027, to regain compliance and intends to seek shareholder approval for a reverse stock split to address the deficiency.
- Counterparty
- Nasdaq
- Term
- 180 days